Top Japanese Stocks To Own Right Now

U.S. stocks opened lower this morning, with the S&P 500 (SNPINDEX: ^GSPC  ) and the narrower, price-weighted Dow Jones Industrial Average (DJINDICES: ^DJI  ) down 0.31% and 0.26%, respectively, at 10:15 a.m. EDT.

Perhaps investors have been spooked by the Japanese market. Stock market losses have been as consistent as the sunrise lately in the Far Eastern country, where the Nikkei 225 fell for the fourth straight today. These are not small losses, either: After a 3% drop on Friday, the Nikkei 225 suffered another 3.3% loss on Monday. The cumulative loss since last Tuesday stands at 6.7%.

Last Friday, the CBOE Volatility Index, or VIX (VOLATILITYINDICES: ^VIX  ) , closed at 12.72, its lowest level since May 17 and well below its long-term historical average, which is above 20. At first glance, that looks entirely defensible. After all, the VIX, which is calculated from S&P 500 option prices, reflects investor expectations for stock market volatility over the coming 30 days. That period now essentially coincides with the month of August -- traditionally, the doldrums for the stock market as traders and investors exchange their trading desks for a lounge chair.

Top 10 Services Stocks For 2015: Target Energy Ltd (TEXQY)

Target Energy Limited is an Australia-based company engaged in the development, production and exploration of oil and gas in the United States of America. During the fiscal year ended June 30, 2012, the Company continued to develop and explore its oil and gas prospects in Texas and Louisiana. The Snapper wells in St Martin Parish, the Pine Pasture #1 and #2 wells in the East Chalkley field, the Merta #1 well at the Highway 71 prospect continued to produce. The Merta #1 well at the Highway 71 prospect continued to produce. Drilling commenced in the Fairway project on September 10, 2011, with the BOA 12 #1 well being completed as a producer. On August 12, 2012, the Darwin #1 well was drilled to a total depth of 3,070 meter. It is located three kilometer north-east of the BOA wells and will test both the Wolfberry and Fusselman formations. The Company�� subsidiaries include TELA (USA) Inc, TELA Louisiana Limited Inc, TELA Texas Holdings Limited Inc and Target Energy Limited. Advisors' Opinion:

• [By CRWE]

  Target Energy Limited (OTCQX:TEXQY, ASX:TEX) (http://targetenergy.com.au/)�is an oil and gas exploration and production company listed on the Australian Securities Exchange and trading under ticker “TEX” and OTC Markets�trading under�ticker “TEXQY”.

  Today (June 19), Target Energy Limited ticker (OTCQX:TEXQY)��has remained�(0.00%) +0.000 at $7.90 thus far (ref. google finance Delayed: 3:45PM EDT June 19, 2013), and Target Energy Limited on the Australian Securities Exchange ticker (ASX:TEX) remained�(0.00%) +0.000 at $.065 (ref. google finance June 17, 2013 – Close).

  Target Energy Limited�previously reported that the company is continuing drilling operations at the Pine Pasture #3 oil well on their East Chalkey Oil Field in Parish, Louisiana. The Company had independent studies which indicated that put upside recoverable reserves for Pine Pasture #3 range between 250,000 and 450,000 barrels of oil. In addition, the report also revealed that the East Chalkey Field has an upside estimate of 4 million barrels of oil.

• [By CRWE]

  Target Energy Limited (OTCQX:TEXQY, ASX:TEX) (http://targetenergy.com.au/) is an oil and gas exploration and production company listed on the Australian Securities Exchange and trading under ticker “TEX” and OTC Markets trading under ticker “TEXQY”.

  Today (June 25), Target Energy Limited ticker (OTCQX:TEXQY) has remained (0.00%) +0.000 at $7.00 thus far (ref. google finance Delayed:�9:32AM June 25, 2013 – Close), and Target Energy Limited on the Australian Securities Exchange ticker (ASX:TEX)�closed at�(+2.99%) +0.002 at $.069 with 50,000 shares in play at the close (ref. google finance June 25, 2013 – Close).

  Target Energy Limited previously reported that the company is continuing drilling operations at the Pine Pasture #3 oil well on their East Chalkey Oil Field in Parish, Louisiana. The Company had independent studies which indicated that put upside recoverable reserves for Pine Pasture #3 range between 250,000 and 450,000 barrels of oil. In addition, the report also revealed that the East Chalkey Field has an upside estimate of 4 million barrels of oil.

Top Japanese Stocks To Own Right Now: Bayerische Motoren Werke AG (BMW)

Bayerische Motoren Werke AG is a German holding company and automobile manufacturer that focuses on the automobile and motorcycle markets. It divides its activities into the three main segments: Automobiles, Motorcycles and Financial Services. It owns three brands: BMW, MINI and Rolls-Royce. Its BMW automobile range encompasses the 1 Series, including three-door, five-door, coupe and convertible models; the 3 Series, including sedan, touring, coupe and convertible models; the 5 Series, available in sedan and touring models; the 6 Series, available as a coupe or convertible; the 7 Series large sedan; the Z4 roadster and coupe; the sports utility vehicles, X3, X5 and X6 and M models, such as M3, M5 and M6. It also offers cars under the MINI brand and motorcycles under the BMW brand. The Rolls-Royce brand offers three luxury cars, Phantom, Coupe and Ghost. It has producing, assembly, service and sales subsidiaries throughout the world. In January 2013, it sold its Husqvarna brand. Advisors' Opinion:

• [By Inyoung Hwang]

  Bayerische Motoren Werke AG (BMW) dropped 2.9 percent after the world�� biggest maker of luxury vehicles reported a decrease in third-quarter profit. Siemens AG (SIE) lost 1.3 percent after UBS AG cut its rating on Europe�� largest engineering company. Beiersdorf AG (BEI) rallied 5.3 percent after increasing its full-year sales forecast.

• [By Jonathan Morgan]

  Bayerische Motoren Werke AG (BMW) and Volkswagen AG (VOW) lost more than 2.5 percent as a gauge of automakers posted the biggest drop on the Stoxx Europe 600 Index. Bayer, Germany�� largest drugmaker, retreated 4.3 percent after a U.S. court ruled that its patent to produce the birth-control pill Yaz was invalid. BASF slid 3.8 percent as a gauge of chemical companies slipped.

• [By Tom Stoukas]

  Deutsche Lufthansa AG (LHA) and Allianz SE (ALV) led airlines and insurers lower, retreating at least 1.5 percent. Bayerische Motoren Werke AG (BMW) slid 1.6 percent. Deutsche Bank AG (DBK) rose after JPMorgan Chase & Co. boosted its recommendation on the shares. Gildemeister AG (GIL) added 3.4 percent after Deutsche Bank upgraded the maker of cutting tools.

• [By Namitha Jagadeesh]

  Bayerische Motoren Werke AG (BMW) dropped 0.8 percent to 73.01 euros. The world�� biggest maker of luxury cars said second-quarter earnings before interest and taxes slid 8.8 percent to 2.07 billion euros. Chief Executive Officer Norbert Reithofer said he doesn�� see the European car market rebounding until the second half of 2014.

Top Japanese Stocks To Own Right Now: Titan Pharmaceuticals Inc (TTNP.OB)

Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.

Probuphine

Probuphine is the first product to utilize the Company�� ProNeura long-ter m drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.

Iloperidone

Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ! i! loperidone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.

Spheramine

Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated wit h human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.

Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide deve lopment, manufacturing and commercialization rights, an! d, in! ad! dition! to the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.

Advisors' Opinion:

• [By C.R. Jackson]

  Fanapt was discovered by Hoechst Marion Roussel in 1995 as a novel atypical antipsychotic agent. Hoechst was a German life-sciences company that became Aventis Deutschland after its merger with France's Rhône-Poulenc in 1999. When the company joined with Sanofi-Synthélabo in 2004, it became a subsidiary of the Sanofi-Aventis (SNY) the French pharmaceutical conglomerate. In 1997, Hoechst sold the research rights to Titan Pharmaceuticals (TTNP.OB). Then Titan quickly sold the worldwide rights to Novartis in 1998. Novartis then sold the Phase 3 development rights for loperidone to Vanda in 2004. Vanda originally attempted to get FDA approval for Fanapt in 2008, but the FDA refused to approve iloperidone. The agency required an additional clinical trial.

Top Japanese Stocks To Own Right Now: eHealth Inc.(EHTH)

eHealth, Inc. offers Internet-based insurance agency services for individuals, families, and small businesses in the United States. The company also offers technology licensing and Internet advertising services. Its ecommerce platforms organize and present health insurance information in various formats, as well as enables individuals, families, and small businesses to research, analyze, compare, and purchase various health insurance plans. The company offers various medical health insurance coverage plans, such as preferred provider organization, health maintenance organization and indemnity plans, Medicare plans, short-term medical insurance, student health insurance, and health savings account eligible health insurance plans, as well as ancillary plans, such as dental, vision, and life insurance. Its customers access its ecommerce platforms through its Websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, and PlanPrescriber.com, as well as through a network of marketing partners. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Advisors' Opinion:

• [By Sean Williams]

  The other option here is eHealth (NASDAQ: EHTH  ) �a private health insurance platform for individuals, families, and small businesses that's been around for years. In its third-quarter results released last week, eHealth noted that membership had risen by 24% to 1.147 million from the year-ago period, clearly showing skepticism in the Obamacare health reform law suggesting the success and options its private platform offers. If there's any company that can use Healthcare.gov's nightmarish start to its advantage, it's eHealth!

• [By David Williamson]

  Obamacare is racking up expenses, in particular, with the creation of insurance exchanges. In this video, David Williamson looks at this feature of Obamacare, and a possible free market solution. The problem is that these exchanges are proving more expensive than originally thought, up to an estimated $5.7 billion for 2014. No wonder less than half of the states in the country have come on board. One solution is an online insurance exchange. A form of such an exchange already exists. Will it work for a nationwide insurance market?�Hard to say. On the one hand, it could offer small businesses unprecedented access to insurance plans. On the other hand, an online market may simply offer those plans with the best commissions and not the best deals.� (NASDAQ: EHTH  )

• [By Ben Levisohn]

  Stocks finished mix today, though it’s probably more fair to say they hardly moved at all.�Intel�(INTC), Facebook (FB) and�Achillion Pharmaceuticals (ACHN) gained, while�CR Bard�(BCR) and eHealth (EHTH) fell.

Top Japanese Stocks To Own Right Now: Diamond Offshore Drilling Inc. (DO)

Diamond Offshore Drilling, Inc. operates as an offshore oil and gas drilling contractor worldwide. It provides offshore drilling services in both the floater market, such as ultra-deepwater, deepwater, and mid-water; and in the non-floater and jack-up markets. The company operates a fleet of 44 offshore drilling rigs, consisting of 32 semisubmersibles, 7 jack-ups, and 5 dynamically positioned drillships, of which 4 are under construction. It serves independent oil and gas companies, and government-owned oil companies. The company was founded in 1989 and is headquartered in Houston, Texas. Diamond Offshore Drilling, Inc. is a subsidiary of Loews Corporation.

Advisors' Opinion:

• [By Dimitra DeFotis]

  Among significant moves in energy stocks, the biggest decliner was Pioneer Natural Resources (PXD), down nearly 5%, followed by Nabors Industries (NBR).�Down more than 3%: Halliburton (HAL), Chesapeake Energy (CHK), Anadarko Petroleum (APC), Baker Hughes�(BHI), �Diamond Offshore (DO) and Occidental Petroleum (OXY).

• [By Julius Ferraro]

  Its always great when a company decides to pay its shareholders what they deserve. Whether it be by an activist or simply a company decision, both outcomes usually lead to share appreciation. Two stocks that I choose because they are handsomely rewarding their shareholders and have a great management team are Diamond Offshore (DO) and Transocean (RIG). I believe both of these stocks on a valuation basis have an overall better risk reward than their competitors in the industry.

• [By Ben Levisohn]

  Land drillers / pressure pumpers may be approaching valuation support levels and could be triggered to consolidate if current weakness persists. The theme could nevertheless be premature in offshore drilling as larger players (Diamond Offshore Drilling (DO)/Transocean/Seadrill) are still addressing dividend concerns while smaller companies (Atwood Oceanics (ATW)/Pacific Drilling (PACD)) still trade close to replacement value.

• [By Ben Levisohn]

  Shares of Transocean are unchanged at $40.47 today, while Ensco (ESV) has risen 0.7% to $52.43, Atwood Oceanics (ATW) is little changed at $49.47,�Diamond Offshore�(DO) has risen 0.4% to $47.02 and� Seadrill (SDRL), whose strategy Transocean may be following, has ticked up 0.2% to $34.30.

Top Japanese Stocks To Own Right Now: Rainmaker Entertainment Inc (RNK)

Rainmaker Entertainment Inc. is an animation studio and is a producer of computer generated (CG) animation. Rainmaker provides services producing CG animation of family entertainment over various entertainment media, including television, digital versatile disc (DVD), gaming and theatrical films. As of December 31, 2011, the Company delivered 42 films based on international brands, such as Barbie, Hot Wheels, Spiderman, Casper, Popeye, Tony Hawk, Stuart Little and Inspector Gadget. In 2011 the Company completed Luna, an animated short film. Rainmaker also produces feature length direct to DVD films for many top international brands including Barbie, Max Steele, Tony Hawk, and more for clients such as Mattel, Sony, and Lions Gate. Rainmaker completed the production of Barbie: Princess Charm School and Barbie in A Mermaid Tale 2 for the series starring Barbie. In December 2011, the Company completed the sale of its remaining interest in Base 10 Group Inc. (Base 10). Advisors' Opinion:

• [By Inyoung Hwang]

  Rank Group Plc (RNK) fell 2.6 percent to 150 pence, falling for a fifth day. The casino operator said it expects full-year operating profit to be marginally below analysts��projection.